VIR
VIR
US92764N1028
Vir Biotechnology, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 66.520.000 63.712.000
4.4%
Cost of Revenue 26.000 845.000
96.9%
Gross Profit 66.494.000 62.867.000
5.8%
546.004.000 615.037.000
11.2%
Operating Income -479.510.000 -552.170.000
13.2%
Pretax Income -437.770.000 -523.105.000
16.3%
Net Income Common Stockholders -437.987.000 -521.960.000
16.1%
-- --
--
-- --
--
ende